Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2007-12-28Clinical Trial Update: BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [Phase 1]
The update indicates that the Phase 1 trial of the BL22 immunotoxin for relapsed or refractory acute lymphoblastic leukemia or non-Hodgkin l…
-
CLINICAL_TRIALS research · 2007-05-07Clinical Trial Update: Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study of AQ4N in patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small …
-
CLINICAL_TRIALS research · 2007-03-26Clinical Trial Update: Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation [Phase 3]
A Phase 3 clinical trial update from Technische Universität Dresden evaluates Helicobacter eradication followed by radiation therapy for lym…
-
CLINICAL_TRIALS research · 2007-02-27Clinical Trial Update: Study Combining Zevalin With High-Dose Chemotherapy Prior to Autologous StemCell Transplant in Patients With Relapsed, Refractory, or Transformed Non-Hodgkin's Lymphoma [Phase 2]
This document reports on a Phase 2 clinical trial evaluating the combination of Zevalin with high-dose chemotherapy before autologous stem c…
-
CLINICAL_TRIALS research · 2006-10-11Clinical Trial Update: Dual Time Point PET Imaging in Lymphoma
This is a clinical trial update evaluating dual time point PET imaging in Hodgkin lymphoma and non-Hodgkin lymphoma. The current trial statu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2006-10-06Clinical Trial Update: Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma [Phase 1, Phase 2]
This clinical trial update describes a risk-adapted therapy optimization approach for patients with relapsed or refractory aggressive non-Ho…
-
CLINICAL_TRIALS research · 2006-06-26Clinical Trial Update: Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation [Phase 2]
This update covers a Phase 2 trial evaluating single-unit or double-unit cord blood transplantation for hematologic malignancies, including …